Vincerx Pharma, Inc. Comprehensive Income
Vincerx Pharma, Inc. reported Comprehensive Income of -$4.95 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2025-05-15
- Vincerx Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-03-31 was -$4.95M.
- Vincerx Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-12-31 was -$7.98M.
- Vincerx Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-09-30 was -$7.76M.
- Vincerx Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-06-30 was -$1.84M.
- Vincerx Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$29.96M.
- Vincerx Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$40.12M.
- Vincerx Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$62.99M.
- Vincerx Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$39.33M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-03-31 | -$4.95M 10-Q · filed 2025-05-15 | -$12.93M derived: sum of 2 quarters · filed 2025-05-15 | -$20.69M derived: sum of 3 quarters · filed 2025-05-15 | -$22.54M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2024-12-31 | -$7.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$15.74M derived: sum of 2 quarters · filed 2025-03-27 | -$17.59M derived: sum of 3 quarters · filed 2025-03-27 | -$29.96M 10-K · filed 2025-03-27 | |||
| 2024-09-30 | -$7.76M 10-Q · filed 2024-11-12 | -$9.61M derived: sum of 2 quarters · filed 2024-11-12 | -$21.98M 10-Q · filed 2024-11-12 | -$26.98M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2024-06-30 | -$1.84M 10-Q · filed 2024-08-08 | -$14.22M 10-Q · filed 2024-08-08 | -$19.21M derived: sum of 3 quarters · filed 2025-05-15 | -$28.24M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2024-03-31 | -$12.38M 10-Q · filed 2025-05-15 | -$17.37M derived: sum of 2 quarters · filed 2025-05-15 | -$26.39M derived: sum of 3 quarters · filed 2025-05-15 | -$37.91M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$14.02M derived: sum of 2 quarters · filed 2025-03-27 | -$25.53M derived: sum of 3 quarters · filed 2025-03-27 | -$40.12M 10-K · filed 2025-03-27 | |||
| 2023-09-30 | -$9.02M 10-Q · filed 2024-11-12 | -$9.73M 10-Q · filed 2023-11-14 | -$20.54M derived: sum of 2 quarters · filed 2024-11-12 | -$35.13M 10-Q · filed 2024-11-12 | -$46.35M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$11.52M 10-Q · filed 2024-08-08 | -$11.12M 10-Q · filed 2023-08-07 | -$26.11M 10-Q · filed 2024-08-08 | -$25.40M 10-Q · filed 2023-08-07 | -$37.33M derived: sum of 3 quarters · filed 2024-08-08 | -$54.27M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$14.59M 10-Q · filed 2024-05-14 | -$14.28M 10-Q · filed 2023-05-11 | -$25.81M derived: sum of 2 quarters · filed 2024-05-14 | -$42.76M derived: sum of 3 quarters · filed 2024-05-14 | -$61.17M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | -$11.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$28.17M derived: sum of 2 quarters · filed 2024-03-29 | -$46.58M derived: sum of 3 quarters · filed 2024-03-29 | -$62.99M 10-K · filed 2024-03-29 | -$65.37M 10-K · filed 2023-03-28 | ||
| 2022-09-30 | -$16.95M 10-Q · filed 2023-11-14 | -$35.36M derived: sum of 2 quarters · filed 2023-11-14 | -$51.77M 10-Q · filed 2023-11-14 | -$58.24M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | -$18.41M 10-Q · filed 2023-08-07 | -$34.82M 10-Q · filed 2023-08-07 | -$41.29M derived: sum of 3 quarters · filed 2023-08-07 | -$65.84M derived: sum of 4 quarters · filed 2023-08-07 | |||
| 2022-03-31 | -$16.41M 10-Q · filed 2023-05-11 | -$22.88M derived: sum of 2 quarters · filed 2023-05-11 | -$47.43M derived: sum of 3 quarters · filed 2023-05-11 | -$49.46M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$6.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$31.02M derived: sum of 2 quarters · filed 2023-03-28 | -$33.05M derived: sum of 3 quarters · filed 2023-03-28 | -$39.33M 10-K · filed 2023-03-28 | |||
| 2021-09-30 | -$24.54M 10-Q · filed 2022-11-10 | -$26.58M derived: sum of 2 quarters · filed 2022-11-10 | -$32.85M 10-Q · filed 2022-11-10 | -$49.13M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | -$2.03M 10-Q · filed 2022-08-11 | -$8.31M 10-Q · filed 2022-08-11 | -$24.59M derived: sum of 3 quarters · filed 2022-08-11 | -$24.89M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | -$6.28M 10-Q · filed 2022-05-12 | -$22.55M derived: sum of 2 quarters · filed 2022-05-12 | -$22.86M derived: sum of 3 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$16.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$16.58M derived: sum of 2 quarters · filed 2022-03-29 | -$16.62M 10-K · filed 2022-03-29 | ||||
| 2020-09-30 | -$307.00K 10-Q · filed 2021-11-12 | -$344.00K 10-Q · filed 2021-11-12 |